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ABSTRACT:
Introduction:  Tuberculosis (TB) remains a significant public health
challenge in Solomon Islands. Limited healthcare resources,
geography, and sociocultural beliefs, coupled with lack of
laboratory diagnostic tools, leads to diagnostic and treatment
outcome uncertainty.
Methods:  Kirakira Hospital (KKH) is the main provincial hospital of
Makira-Ulawa Province in Solomon Islands. A retrospective clinical
audit of hospitalised TB patients in KKH over a 2-year period
between July 2015 and July 2017 was conducted. The cost of TB
treatment was estimated by calculating the total number of
inpatient bed days of treatment.
Results:  Data were available for 42 of 78 listed TB patients
including 23 males and 19 females, and 9 children aged less than
16 years. The average age was 35 years (range 9 months –
74 years). Thirty-five of these received a chest X-ray. All patients
had at least one of the following: fever, night sweats, chronic
cough and haemoptysis as part of their clinical TB presentation.
Thirty-six completed the full 8-week duration of intensive HRZE
treatment as inpatients of KKH. The audit shows the treatment of
TB consumes 15% of the current healthcare budget of Makira-
Ulawa Province.
Conclusion:  TB remains a common clinical diagnosis in KKH. TB
consumes 15% of the current healthcare budget of Makira-Ulawa
Province. The limited capacity and data about the management of
TB in Makira province mean that it is not currently possible to
measure if there has been any progress towards eradicating TB in
Solomon Islands. Laboratory investigations for TB available in
Makira including sputum analysis and the GeneXpert are required
to improve the accuracy of diagnosis and identify multidrug
resistant strains of TB. This needs to be coupled with robust
monitoring and data collection of both inpatients and outpatients
to ensure the current treatment protocols for TB are being
followed in Makira-Ulawa Province. These steps are essential if TB
is to be eradicated from the provinces of Solomon Islands by 2030.
Keywords:
audit, healthcare resources, Solomon Islands, sputum analysis, tuberculosis.
FULL ARTICLE:
Introduction
Through the Sustainable Development Goals, aided by the
encouraging outcomes of the Millennium Development Goals, the
international community has boldly aimed to end the tuberculosis
(TB) epidemic by 2030 . The Millennium Development Goals have
seen TB prevention, diagnosis and treatment interventions save
approximately 37 million lives worldwide between the years 2000
and 2013 . Treatment success rates have been reported at or
above 85% since 2007 . In most countries in the Western Pacific
region, the reported TB prevalence has decreased by 50% and the
mortality rate reduced by more than 70% .
Despite these reported advances, TB remains a problem in
Solomon Islands. In 2015, the new case rate for TB in Solomon
Islands was estimated at 66/100 000, with an incidence of
89/100 000 (including new and relapsed cases) and a fatality rate
of 9.8/100 000 . The Solomon Islands population is geographically
dispersed across over 900 islands with approximately 80% of the
community living in rural or remote areas . In Solomon Islands,
limited healthcare resources, geography and sociocultural beliefs
contribute to low detection rates and delayed treatment,
facilitating the continued spread of the disease, particularly in
remote provinces. The two principal sociocultural beliefs that have
been identified as hindering the treatment of TB Solomon Islands
revolve around the challenge of translating the concept of TB into
local language and the challenge to have patients continue to take
medication when they feel well. These beliefs mean there is a
reduced rate of people presenting for treatment in hospital and a
likely low level of compliance with completing the full course of
prescribed TB treatment .
The health system in Solomon Islands comprises the National
Referral Hospital (NRH) in Honiara, supported by a network of
seven provincial hospitals (staffed by just one to three doctors)
and small community clinics and aide posts occupied by either
registered or enrolled nurses . The medical workforce is
predominantly based at the NRH where over 70% of doctors and
the entire specialist medical workforce for the nation are
employed .
For most suspected TB cases in Solomon Islands there is no access
to laboratory confirmation of the diagnosis . In resource-poor
countries, there exists great difficulty obtaining accurate clinical
data that reflects the community as a whole . This is true in
Solomon Islands where the ability to measure clinical outcomes
outside of the NRH is particularly limited.
This clinical audit on TB management in a remote provincial
hospital setting was performed to gain baseline information
regarding the current state of TB diagnosis and hospital-based
care in an indicative remote province in Solomon Islands. The
published data on currently achieved health outcomes can be
inaccurate. A recently published study has documented that the
current perinatal mortality rate in Kirakira Hospital (KKH) is more
than double what is reported by the WHO as it monitors the
progress of the Millennium and Sustainable Development Goals .
The desired outcome of the audit was to provide data from which
future clinical quality improvement implementation projects might
be performed to assist the people of Makira-Ulawa to not be left
behind the global community’s quest to achieve the goal of
eradicating TB by 2030.
Context 
Kirakira is the provincial capital of Makira-Ulawa Province in
1,2
3
1
4
5
6
7
8
8
9
10
11
Solomon Islands. It is a small town of approximately 3500 people
and is located 200 km south-west of Honiara . It is accessible by
air and boat. The provincial population was measured at 40 000 in
2009 . KKH is the provincial hospital and main healthcare facility
of Makira-Ulawa Province. The main Island of Makira is 100 km
long and 40 km wide. A steep mountain range runs along the
spine of the island, which rises to 400 m above sea level. The
terrain is thick jungle.
The one gravel road along the northern coast line runs for 40
kilometres. Public transport consists of a small flat-top truck that
runs back and forth along the gravel road. People often must walk
long distances to get to the road so they can catch the flat-top
truck. About a dozen people can fit on the back of the truck at any
one time. People can climb aboard to get a lift to Kirakira. Kirakira
sits in the middle of the one road of Makira-Ulawa Province.
To access KKH, patients on the coastline will travel by boat, which
is usually a small open vessel with an outboard motor. Those living
inland will often walk for 1–2 days through the jungle before
catching the truck into Kirakira in order to visit the hospital. The
financial cost of transport is very expensive in terms of time and
money for the people in Kirakira and it is an impediment to being
able to seek care, and makes coordinated follow-up of cases like
TB very difficult.
Bacillus Calmette–Guérin (BCG) vaccination is included as part of
the immunisation schedule in Solomon Islands. In 2017 the
estimated coverage for BCG was 79% according to WHO and
UNICEF estimates . BCG testing is not available in Makira-Ulawa
Province.
The provincial health service is staffed by 2 doctors and 60 nurses.
Approximately half of the nurse workforce is stationed at smaller
rural health clinics and nurse aid stations across the province . The
hospital is a 40-bed facility that includes an emergency
department, male and female wards, a children’s ward, a maternity
unit and an isolation ward where TB patients are admitted. The
KKH health service employs a registered nurse who has
responsibility for the management of suspected TB patients in the
province. Up to 2017, the diagnosis of TB was made based on
clinical suspicion confirmed on X-ray or based on the patient living
in the same house as the index patient. In KKH there are two
rooms, one male and one female, for the treatment of adult
patients with a diagnosis of TB in the hospital. The children are
managed in a back room of the children’s ward and ideally there
are no children alongside them without TB. This part of the
children’s ward is adjacent to the two TB treatment rooms. The
separation of the affected children is the best that can be achieved
with the facilities available.
The immediate household contacts and the children of the index
case are also admitted for treatment. It is amongst this group of
patients that there was a very low level of clinical documentation.
It is likely that most of the cases recorded by the TB nurse for
whom there were no recorded admissions came from this group of
patients.
KKH does not have the capacity to perform standard
microbiological facilities to allow for bacteriological assessment for
infection. There is no capacity to perform blood, urine,
cerebrospinal fluid or skin cultures (Mantoux testing). The only
pathology tests that can be performed include a full blood count,
blood glucose level, urine microscopy, thick and thin film analysis
for malaria, serology for hepatitis, syphilis and HIV and blood
group cross-matching. Extrapulmonary TB can be diagnosed
radiographically (if there is X-ray film in stock) for suspected
osteomyelitis. Meningitis is solely a clinical diagnosis in KKH. 
Up until April 2015 there was the capacity to confirm a suspected
diagnosis of TB in KKH using a Zeil-Nielsen stain that could
confirm the presence of acid-fast bacilli. Due to lack of resources,
personnel and equipment becoming unserviceable, there was no
capacity to perform sputum testing again until 2017. From August
2017 the capacity to perform sputum smears for acid-fast bacilli
was restored. In the next 12 months there were 26 positive smears
identified from 69 patients who were tested for TB because of
clinical suspicion. It is hoped that KKH will have an operational
GeneXpert test to allow for the detection of multi-drug resistant
TB (MDR-TB) by 2019.
There are no other microbiological or DNA diagnostic capabilities
available in Kirakira.  
TB treatment in Makira-Ulawa Province follows the WHO
guidelines . The intensive phase consists of combination therapy
with four drugs: isoniazid, rifampicin, pyrazinamide and
ethambutol (HRZE), administered by directly observed therapy
whilst the person is an inpatient in the TB ward of KKH for a period
of 8 weeks. Patients are then discharged home and required to
take a further 4 months of maintenance treatment with isoniazid
and rifampicin (HR). The TB nurse follows up the care of these
patients in the community supported by the nurses based at the
various rural and area health centres to help ensure compliance
with treatment. Directly observed taking of medication for the
maintenance treatment of TB is not part of the current
management practice of TB in Makira-Ulawa Province. Previously,
the names of all patients managed by the TB nurse were recorded
in an exercise book that was used to help coordinate follow-up
and monitoring of these patients.
The families admitted for TB (or close household exposure with TB)
are required to live in the TB rooms in the hospital for the duration
of their intensive phase treatment. This is done as a quarantine
procedure to prevent the spread of disease. Another benefit of this
procedure is that patients are compliant with their medication
while in hospital. Following admission to hospital, there is little
daily medical input involved in the care of these patients, who are
predominantly fully independent with all their personal cares whilst
in hospital.
In Solomon Islands all individuals carry with them a small exercise
book, which is their own personal medical record. It contains the
written notes made by each of the nurses and medical staff that
have seen the patient. These notebooks are invaluable resources
when clinicians are seeing an individual patient and trying to work
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out the next stage of treatment they require. There are however,
major limitations of the system. There are no formal records of
clinical consultations retained by the health service. The fact that a
patient has been seen is recorded, but there are no means to
document or audit any of the clinical details or outcomes achieved
to measure the effectiveness of any of the treatments. In Solomon
Islands only 2% of deaths are registered, which makes it even more
challenging to estimate what might be the real outcome for the
patients being managed. These facts mean that claims of what the
actual outcomes might be are unlikely to be supported by detailed
clinical audits and remain very approximate estimates . 
Methods
The hospital files of patients identified as having TB treatment by
the TB nurse over the 2-year period (between 2015 and 2017) were
retrieved from the hospital medical records department. The files
were then assessed by final-year medical students from Bond
University as part of a 1-month clinical placement at KKH.
For the duration of the audit, a patient with a chronic cough and
night sweats with associated abnormal X-ray findings was
considered to have TB. The cough was considered chronic if it was
recorded in the admission that the patient had daily symptoms of
cough. If the admission record stated the presence of haemoptysis,
fever of any kind and weight loss the symptom was regarded as
present. There was no data to indicate the frequency or volume of
coughing up blood, how high the fever was or how much weight
had been lost.
Ethics approval
The study was approved by Bond University Human Research
Ethics BUREC 15097 and by the KKH Medical Administration
committee.
Results
The results of the study are summarised in Table 1. From June 2015
to June 2017 there were 78 patients recorded as having TB by the
TB nurse. Detailed inpatient clinical data were available for 54% (42
of 78) of TB patients. There was no documented reason for no
available data recorded on the remaining 36 patients identified as
having TB.
The most common presenting complaint for tuberculosis identified
by the audit was chronic cough (90%), followed by fever (59%). At
KKH, chest X-rays were performed in 83% (35 of 42) of patients
with suspected TB. There is only one radiographer based at KKH. If
the radiographer is on leave during this time, patients are admitted
to the ward without performing an X-ray. Eighty-six percent (36 of
42) of patients complied with completing the full 8-week
admission to hospital. Only 14% (6 of 42) of patients did not
comply and were admitted for 4 weeks or less. The average length
of stay for each patient was 51 days. The average number of
patients on the TB ward for whom data were collected was 3.8 on
any given day during the 2-year period.
In Solomon Islands it is estimated that each admission to hospital
for TB costs US$5925 . This should not be surprising given the
average length of stay identified by this audit was 51 days at KKH.
Thus, with approximately 39 cases per annum being managed by
the TB nurse, US$231,000 is being spent on the management of TB
at KKH each year. This equates to 15% of the available healthcare
resources in Makira-Ulawa Province being allocated for the
treatment of TB .
Table 1:  Summary of medical records of tuberculosis patients admitted to isolation ward of Kirakira Hospital, July 2015 – July
2017.
Discussion
This audit provides a snapshot of the current care and clinical
practice with respect to the management of TB in Makira-Ulawa
Province between July 2015 and July 2017. It confirms that the
treatment of TB consumes a significant portion of the scarce
resources available for health care at KKH and within the Makira-
Ulawa Province of Solomon Islands . A total of 15% of the budget
allocated for all health care for Makira-Ulawa Province in 2017
(including KKH and all outreach stations) of US$1.5 million is spent
on the inpatient treatment of TB patients in KKH.
There are many limitations to this audit. Written data were
available on only 42 of 78 patients. There is no microbiological
confirmation of TB, and the outcome of any of the cases and how
often patients completed the full course of TB treatment are
unknown. The written documentation on each patient is limited.
There are new cases and recurrent cases included in this audit. It
was not possible to identify which was which. It is not possible to
make any estimate of the incidence and prevalence of TB in the
community or to measure the effectiveness of current treatment
protocols.
The quantitative data in this study has limitations: almost 50%
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attrition, lack of follow-up and no information about patient
adherence beyond 2 months. Unless these data are reported, the
reality of the limitations that confront clinical practitioners in
resource-poor communities around the world will continue to go
unnoticed. The concern is that the reported WHO statistics, with
calculations based on estimates often made at a distance from
their subject, that currently measure improvements in progress
towards meeting the Millennium Goals, are accepted as accurate;
the real data that this audit presents suggests that is most likely
not the case. The global community might believe we are closer to
eradicating problems such as TB in the Pacific than what is
happening where 80% of the population of Solomon Islands live.
The population of Makira-Ulawa Province at the last census in
2009 was recorded as 40 900 . This means that if the KKH TB
nurse is recording all cases of treatable TB in Makira-Ulawa
Province, then the current estimated incidence (consisting of new
and recurrent cases each year) of TB) identified in this audit is 97
cases per 100 000. This statistic is just above the 2017 WHO
estimated range of new and recurrent cases of TB in Solomon
Islands of 76 (range 58–96) . The population is very dispersed in
extremely remote communities across Makira-Ulawa Province. It is
difficult to imagine that all known cases of TB have been identified
by the single coordinating nurse. Given the recent experience of
seeing many Laboratory confirmed cases in the time since the
capacity to perform sputum analysis for acid-fast bacilli, it is most
likely that the number of cases is indeed higher and that there is
an ongoing epidemic of TB in this community.
There is no way of knowing if the patients who have been treated
for TB really had TB and what happens to them on follow-up. In
Solomon Islands the provincial health services do not carry a
record of the clinical details of outpatient consultations. Instead,
patients have their own personal medical record book. It is a
valuable resource that certainly provides much-needed data to
guide clinical interactions; however, there is no system to allow the
health service to collect clinical data about these patient
encounters. Therefore, the clinical outcomes achieved through
outpatient follow-up are unknown in the Makira-Ulawa Province in
Solomon Islands.
Data collection systems for hospital inpatients are also limited.
There are three possible reasons that inpatient data was only
available for 42 of 78 patients. First, the inpatient notes confirm
that 100% of patients who received a formal medical admission
had at least one clinical symptom of TB. No asymptomatic patients
appeared to receive a formal medical admission for intensive
treatment. This is despite many symptom-free community
members being at high risk of contracting TB (eg having close
household contacts). Second, there is the potential that several
records might have been lost and unable to be found at the time
of the audit. Third, the nurse may not have recorded patient
details.
There exist readily available tools that would substantiate the
diagnosis of TB at KKH and have been successfully utilised in other
resource-poor settings around the world. The acid-fast bacilli test
is one of the quickest and most cost-effective modes of
diagnosis . Until April 2015, acid-fast bacilli tests were performed
at KKH. A combination of equipment maintenance, staff expertise
and limited funding appears to be responsible for this loss of
diagnostic capacity at KKH.
In the developing world, the WHO recommends the use of new
diagnostic testing such as GeneXpert, a molecular test that can use
a sputum sample to detect the DNA in TB bacteria and determine
if the strain is likely to be MDR-TB and provide a result in less than
2 hours . Whilst economical by Western standards, the high cost
of diagnostic equipment, at US$17,000 (an individual test costs
US$9.98), and the need for staff training and equipment
maintenance mean such an investment in resources has been
unattainable at KKH . This is not surprising when the total budget
for health care in Makira-Ulawa Province is just US$30 per person
per annum for all primary and secondary hospital health
services . MDR-TB is an infection that causes significant concern
to public health physicians around the world. A growing reservoir
of partially treated and new cases of TB would certainly increase
the risk of an outbreak of this infection in nearby wealthy countries
like Australia and New Zealand. Not only is there an imperative to
improve the management of TB in Makira-Ulawa Province for the
sake of the local population, failing to appropriately manage this
epidemic has the potential to cause far greater harm in the future
to the entire regional population of Oceania.
The lack of current investment in the treatment of TB at KKH
suggests that the gains achieved through the Millennium
Development Goals may be at risk in the provinces of Solomon
Islands. An almost 50% reduction in expenditure used for TB
management between 2012 and 2016 is a concern . Although
Makira-Ulawa is a remote province, the reality is that there is a
substantial risk of disease spread to adjacent countries given the
relative ease of international travel in 2017. The problem of having
inadequate resources to manage the TB epidemic is a global
health problem where investments need to be made so that
accurate identification, treatment and follow-up can be
documented in rural communities, where so much of the
population lives in the developing world.
The medical and nursing staff do their best in very challenging
circumstances. They identify suspected cases of TB based on
history, clinical symptoms and plain X-ray findings. They have
achieved a commendably high rate of compliance, with 86% of
patients remaining as inpatients and completing 8 weeks of
observed treatment to ensure full compliance with the intensive
phase of TB treatment. However, key weaknesses identified in this
audit are the lack of any laboratory-based confirmation of TB
diagnosis at the time of admission and the absence of data
available on patients at the time of completion of their treatment.
Makira-Ulawa Province is the fourth largest of nine in Solomon
Islands. The care provided in KKH is likely to be consistent with the
care offered in other small and resource-poor hospitals across the
Pacific. Publication of this data, despite its limitations, highlights
that there is a current TB epidemic, and gives voice to isolated
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communities so they can access the resources required to meet
the challenge of eliminating TB.
Conclusion
This audit confirms that the diagnosis and treatment of TB remain
a common problem that is encountered at KKH in Makira-Ulawa
Province in Solomon Islands. The audit highlights that despite TB’s
apparent prevalence there is a great deal of uncertainty about the
diagnosis of TB in KKH and there exists no effective means of
being able to be confidently reassured that affected people have
been successfully cured of the disease. This report should serve as
a wake-up call to those who may feel reassured at the reported
progress achieved in the era of Millennium Goals. Just as we have
seen recently with malaria rates of detection increasing, TB remains
a major threat to the global community . There needs to be
comprehensive support provided to allow for accurate data
collection systems, equipment and staff training if the goal of
eradicating TB from Makira-Ulawa Province is to be achieved by
2030.
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